Safety and Effectiveness and Effect on Quality of Life and Work Productivity of Humira in Patients With Psoriatic Arthritis in Clinical Routine

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

NCT00646178 ·Status: COMPLETED ·Phase: PHASE3

Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

NCT01474876 ·Status: COMPLETED

Impact of Adalimumab (Humira®) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice

NCT01754727 ·Status: COMPLETED

A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis

NCT00963313 ·Status: COMPLETED

Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis

NCT00646386 ·Status: COMPLETED ·Phase: PHASE2

Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI])

NCT02414633 ·Status: COMPLETED

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

NCT00234897 ·Status: COMPLETED ·Phase: PHASE4

Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)

NCT01079182 ·Status: COMPLETED

Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis

NCT00051662 ·Status: COMPLETED ·Phase: PHASE1

Drug Use Investigation for Humira® - All Patient Investigation for Rheumatoid Arthritis

NCT01076959 ·Status: COMPLETED

Special Investigation in Patients With Psoriasis Vulgaris and Psoriatic Arthritis (All Patients Investigation)

NCT01155570 ·Status: COMPLETED

Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.

NCT01561313 ·Status: COMPLETED ·Phase: PHASE2

A Crossover Study of the Safety and Tolerability of Two Formulations of Adalimumab

NCT01502423 ·Status: COMPLETED ·Phase: PHASE2

Optimization of Treatment With Adalimumab (Humira)

NCT01585064 ·Status: COMPLETED

Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis

NCT01163318 ·Status: COMPLETED

A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)

NCT02349451 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

NCT00235885 ·Status: COMPLETED ·Phase: PHASE3

Real Life Evaluation of Rheumatoid Arthritis Patients in Israel Treated With HUMIRA

NCT02322723 ·Status: WITHDRAWN

A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )

NCT01078558 ·Status: COMPLETED

Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

NCT04610476 ·Status: UNKNOWN ·Phase: PHASE3

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

NCT02137226 ·Status: COMPLETED ·Phase: PHASE3

Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

NCT04936308 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Quality of Life Study With Adalimumab in Rheumatoid Arthritis

NCT00234936 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid Arthritis

NCT00853385 ·Status: COMPLETED ·Phase: PHASE3

Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care

NCT01163916 ·Status: COMPLETED